$115 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 331 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | LINDE PLC | $103,077,600 | – | 290,000 | +100.0% | 0.09% | – | |
TTD | New | THE TRADE DESK INC | $46,766,698 | – | 767,800 | +100.0% | 0.04% | – |
New | NEXTRACKER INC | $44,578,044 | – | 1,229,400 | +100.0% | 0.04% | – | |
BK | New | BANK NEW YORK MELLON CORP | $29,345,152 | – | 645,800 | +100.0% | 0.03% | – |
GLPG | New | GALAPAGOS NVspon adr | $25,401,047 | – | 657,377 | +100.0% | 0.02% | – |
MRVL | New | MARVELL TECHNOLOGY INC | $21,255,970 | – | 490,900 | +100.0% | 0.02% | – |
FTNT | New | FORTINET INC | $4,586,072 | – | 69,005 | +100.0% | 0.00% | – |
New | SAFEHOLD INC | $1,596,208 | – | 53,600 | +100.0% | 0.00% | – | |
New | THE REAL GOOD FOOD COMPANY I | $42,200 | – | 10,000 | +100.0% | 0.00% | – | |
New | DUOLINGO INC | $335,086 | – | 2,350 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
BIOGEN INC. | 42 | Q3 2023 | 6.8% |
AMGEN INC. | 42 | Q3 2023 | 5.3% |
MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
FEDEX CORP | 42 | Q3 2023 | 3.3% |
SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
NN INC | November 09, 2022 | 1,763,640 | 4.0% |
AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.